Login / Signup

A de-escalated treatment strategy in the management of paediatric cervicofacial actinomycosis.

Justin Jui Yuan YeoMichael Edward HopkinsAidah Isa
Published in: BMJ case reports (2021)
Actinomycosis is a rare invasive bacterial disease that is characterised by granulomatous inflammation often mistaken as malignancy. Traditionally, this has been managed with prolonged courses of antibiotics with durations up to 6-12 months. Surgical intervention as an adjuvant treatment has been shown to reduce the length of antibiotic treatment significantly to 4 weeks. We report a case of cervicofacial actinomycosis in a 12-year-old girl who was adequately treated with an 11-day course of antibiotics without surgical intervention and shows no signs of recurrence at 6 months post-treatment.
Keyphrases
  • randomized controlled trial
  • oxidative stress
  • emergency department
  • intensive care unit
  • rheumatoid arthritis